Of all the lucrative investments Gates has made in the technology industry over the course of his career, his investments in global health have been among his greatest commercial successes, particularly in the area of vaccine development and delivery.
Provision of vaccines
Microsoft billionaire Bill Gates, who famously stepped down from the board of his tech empire last March to become a full-time “philanthropist,” is focusing his efforts on the “best investment” he ever made: funding and providing “vaccines”. Although Gates claims that this is merely a local economic boom, reports suggest that his charity has actually generated more in investment returns in the healthcare industry than it has spent in the last 5 years.
Of all the lucrative investments Gates has made in the technology industry over the course of his career, his investments in the global health industry, particularly in vaccine development and delivery, especially to remote, impoverished peoples, have been among his strongest economic achievements.
Gates’ charity, the Bill and Melinda Gates Foundation, is behind vaccination programs around the world, including the current global push for mass COVID-19 vaccinations using experimental mRNA-derived formulas that Gates admits “no one had ever made before”. The foundation benefits enormously from the introduction of vaccines on a massive scale, despite the enormous health problems that have resulted.
He claimed in the Wall Street Journal op-ed in 2019 that his investments in vaccine rollout programs make a 20-to-1 financial return, turning $10 billion of investment into $200 billion of “economic benefit” to local economies in the twenty-plus years since he entered the healthcare industry.
Of this $10 billion, more than $10 % went to programs to eradicate polio, a virus that can cause temporary or permanent, life-threatening paralysis. Foundation beneficiaries included the Global Polio Eradication Initiative (GPEI) and Gavi, the vaccine alliance that brings oral polio vaccine (OPV) to countries around the world. With the billion-dollar dowry, Gates was able to gain control of India’s National Advisory Board, a government advisory body that influences policy decisions in India’s parliament.
From 2000 to 2017, the Gates’ foundation was responsible for introducing and distributing hundreds of thousands of doses of OPV to children under 5 in India. During that time, in 2014, the World Health Organization announced that the naturally occurring strain of polio had been eradicated in India, three years after the last case was reported in 2011. But a 2018 study found that as OPV rates and 5-year cumulative doses increased, so did the rate of acute flaccid paralysis (AFP) in children under 15.
Robert F. Kennedy Jr, chairman and general counsel of Children’s Health Defense (CHD), a non-profit organization dedicated to fighting childhood health epidemics, wrote that between 2000 and 2017, more than 496,000 children became paralyzed after receiving OPV. Kennedy pointed out that the increase in paralysis was caused by the vaccine variant of the virus that resulted from the Gates-funded OPV, not the naturally occurring virus. This phenomenon occurred in numerous countries.
The 2018 study in the International Journal of Environmental Research and Public Health shows that around 2012, the cumulative dose of OPV and rate of AFP peaks in two Indian provinces before the vaccination program winds down and the rate of AFP declines with reduced administration of OPV.
Indian physician Jacob Puliyel, head of pediatrics at St. Stephen’s Hospital in Delhi and corresponding author of the study on AFP with the frequency of polio vaccine (OPV) administration, noted that “the frequency of polio vaccine administration is directly or indirectly related to the occurrence of acute flaccid paralysis without polio.”
“In the absence of wild polio transmission, cases of paralysis were expected to decline to an acceptable rate of about two per 100,000, but this has not occurred,” he added.
Because his findings indicated a strong relationship between AFP rate and OPV use, Puliyel said in the report that “the response to OPV round reduction (de-challenging) strengthens the hypothesis that OPV was responsible for the change in NPAFP rate.”
“Now that India has been polio-free for over six years, we may be able to reduce NPAFP by further reducing OPV rounds,” the 2018 study concluded.
In 2017, the Indian government drastically cut its polio vaccination program and removed Gates from the National Advisory Board, after which AFP cases dropped significantly. The move coincided with the World Health Organization’s (WHO) admission that the vaccine-induced strain of polio was fast becoming the predominant strain, leading the organization to call for “eliminating” what it called the “rare risks” of vaccine-induced “paralytic polio and vaccine-induced poliovirus” by slowing and eventually halting its use.
COVID 19 vaccine
Now the Gates Foundation is investing heavily in the development and distribution of the COVID 19 vaccine, leading the global campaign for a COVID vaccine. The non-profit announced a $40 million investment in CureVac, a German biotechnology company, last year. This is part of a $250 million investment portfolio of companies developing, manufacturing and testing COVID vaccines.
The Nation reported that Gates’ investment in CureVac alone may have already netted the foundation tens of millions of dollars, as the company’s stock value rose by 431% within two days of its August IPO. Today, it stands at nearly 500% of its original value.
One example of the influence Gates has acquired through his foundation is the vaccine partnership between Oxford and AstraZeneca. The Gates Foundation is a major investor in Oxford University’s vaccine projects and has invested $384 million. In addition, the foundation has given millions of dollars in grants to the university’s Jenner Institute, which is developing Oxford’s COVID-19 vaccine.
Kaiser Health News reported that Oxford had originally agreed to make its mRNA-COVID vaccine open source, releasing the technology to manufacturers without expensive licensing costs; however, after the Gates Foundation intervened, Oxford signed an exclusive license with AstraZeneca. Since then, both Oxford and AstraZeneca have stated that they will not make a profit from the production and distribution of their vaccine “for the duration of the coronavirus pandemic.” After that, they are no longer bound by that promise.
Kaiser pointed out that the vaccine industry has a financial shortfall, as vaccines usually do not bring in much money. After all, they are supposed to protect against viruses for a lifetime. Instead, pharmaceutical companies have traditionally relied on expensive drugs that must be taken repeatedly to remain a profitable business.
However, Gates recently announced that instead of the two shots of mRNA COVID-19 vaccine typically given to people today, he recommends three shots to prevent the spread of new variants of the virus.
His recommendation to increase the dose follows the WHO’s announcement that there is “no evidence that any of the vaccines” are able to “prevent people from actually getting the infection [COVID] and thus passing it on.
Gates explained that “AstraZeneca in particular has a challenge with the variant.”
“And the other two, Johnson & Johnson and Novavax, are a little less effective, but still effective enough that we should definitely get them out as soon as possible while we explore this idea of tuning the vaccine.”
Like Gates, Pfizer CEO Albert Bourla announced Thursday that the vaccine maker is testing a third dose of its vaccine in anticipation of annual booster shots, citing divergent strains of COVID-19 and the ongoing need to adapt vaccines to the evolving virus.
“Every year you should be vaccinated against influenza”, Bourla told NBC News. “It’s going to be the same with COVID. Every year you have to get vaccinated to be protected against Covid.”
“Meanwhile, the policies he and others have promoted are destroying the global economy and demolishing the middle class, making them and others even richer, and censoring vaccine safety advocates like me”.
In addition to funding the AstraZeneca vaccine, the Gates Foundation has given about $20 million in grants to Moderna, which also makes a COVID vaccine that is already approved for “emergency use” in the United States.
On Thursday, Moderna reported 2020 revenue 13 times that of 2019.
“Total revenue was $803 million for the year ended December 31, 2020 compared to $60 million for the year ended December 31, 2019,” the report said, adding that much of the increase was associated with the company’s coronavirus vaccine, mRNA-1273.
“High revenues in the fourth quarter of 2020 and the full year, were driven by increased grant revenue and product sales,” most of which came from a federal award from the Biomedical Advanced Research and Development Authority (BARDA), the report added.
Many of Gates’ other “pandemic” investments remain a mystery.
James Love, director of Knowledge Ecology International, a nonprofit that specializes in intellectual property and public health, criticized Gates for keeping much of his charity’s involvement secret, The Nation reported.
We don’t ask for unreasonable things… We ask, for example, “Can you explain what you are doing? Can you show us what these contracts look like”? Especially since they use their money to influence the policy that affects our taxes”.
That is why, in a series of interviews, including with Wired, Gates concealed his financial interest in drug manufacturer Gilead, which develops and manufactures a drug to fight the virus, Remdesivir. In fact, he told Wired that he would be prescribed the drug if one day he had to go to hospital with COVID-19.
The National Institutes of Health
The National Institutes of Health (NIH) sided behind remdesivir after assembling a COVID-19 Guideline Panel that included 16 members (out of 55) who have or had financial ties to Gilead. In addition to endorsing remdesivir, the panel also rendered a negative verdict on hydroxychloroquine, a competing prophylactic drug. Hydroxychloroquine has been shown to be more effective against mortality after infection with COVID-19 than remdesivir and could prevent hospitalization. Remdesivir is prescribed only after hospitalization.
A 5-day treatment cycle of Remdesivir costs about $3,000, while a 5-day treatment of Hydroxychloroquine costs only $10. Gates has advised people to avoid taking the cheap and readily available drug hydroxychloroquine and instead choose its expensive alternative, which is an investment option.
In television interviews in which he is questioned as a COVID-19 expert, Gates never discloses these conflicts of interest, nor is he ever asked.
While the Gates Foundation makes hundreds of millions of dollars from its vaccine partnerships, Gates’ personal fortune is said to have increased by over $10 billion since March 2020, while many ordinary citizens are already suffering the dangerous side effects of the largely untested mRNA-derived vaccines.
The Oxford/AstraZeneca vaccine and those of its competitors Pfizer/BioNTech and Moderna are being developed using mRNA technology and are currently classified as experimental by the Food and Drug Administration (FDA), although the latter two have FDA “emergency use authorization.”
Since the launch of Pfizer-BioNTech’s COVID-19 vaccine, a total of 1,095 deaths have been recorded in the latest Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS) data from December 15, 2020 to February 18, 2021, representing 5.5 % of the 19,907 adverse events in the system’s report. An additional 2,297 people were hospitalized, 755 of whom were reported to have suffered a life-threatening reaction.